Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells under Xeno-free Conditions
Open Access
- 3 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 28 (1) , 36-44
- https://doi.org/10.1002/stem.248
Abstract
The availability of induced pluripotent stem cells (iPSCs) has created extraordinary opportunities for modeling and perhaps treating human disease. However, all reprogramming protocols used to date involve the use of products of animal origin. Here, we set out to develop a protocol to generate and maintain human iPSC that would be entirely devoid of xenobiotics. We first developed a xeno-free cell culture media that supported the long-term propagation of human embryonic stem cells (hESCs) to a similar extent as conventional media containing animal origin products or commercially available xeno-free medium. We also derived primary cultures of human dermal fibroblasts under strict xeno-free conditions (XF-HFF), and we show that they can be used as both the cell source for iPSC generation as well as autologous feeder cells to support their growth. We also replaced other reagents of animal origin (trypsin, gelatin, matrigel) with their recombinant equivalents. Finally, we used vesicular stomatitis virus G-pseudotyped retroviral particles expressing a polycistronic construct encoding Oct4, Sox2, Klf4, and GFP to reprogram XF-HFF cells under xeno-free conditions. A total of 10 xeno-free human iPSC lines were generated, which could be continuously passaged in xeno-free conditions and maintained characteristics indistinguishable from hESCs, including colony morphology and growth behavior, expression of pluripotency-associated markers, and pluripotent differentiation ability in vitro and in teratoma assays. Overall, the results presented here demonstrate that human iPSCs can be generated and maintained under strict xeno-free conditions and provide a path to good manufacturing practice (GMP) applicability that should facilitate the clinical translation of iPSC-based therapies. STEM CELLS 2010;28:36–44Keywords
Funding Information
- predoctoral fellowship from MEC
- Swiss National Science Foundation
- Ramón y Cajal program
- Ministerio de Educacion y Ciencia (BFU2006-12251)
- Fondo de Investigaciones Sanitarias (TERCEL, PI052847)
- Marató de TV3 (063430)
- Fundación Cellex
- the G. Harold and Leila Y. Mathers Charitable Foundation
- Sanofi-Aventis
This publication has 42 references indexed in Scilit:
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- Virus-free induction of pluripotency and subsequent excision of reprogramming factorsNature, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Induced pluripotent stem cells from a spinal muscular atrophy patientNature, 2008
- Efficient and rapid generation of induced pluripotent stem cells from human keratinocytesNature Biotechnology, 2008
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006